Oncolytic viruses, viral vectors for gene therapy and viral-vectored prophylactic vaccines, are new,...
COVID-19
As the process determines the product, product characteristics of biological drugs need to be analysed...
A biosimilar is a copy version of an approved, original biological medice whose patent protection has expired....
Viennese APEIRON Biologics AG raised €17.5m to expand ongoing Phase II trials of its
coronavirus-specific drug...
Share
